Sarcoidosis is an inflammatory disease in which clusters of immune cells, called granulomas, form in one or more organs. It most often affects the lungs and the lymph nodes in the chest, but it can also involve the skin, eyes, heart, nervous system, liver, kidneys and joints. Its cause is unknown: a trigger, such as a silent infection or a substance in the environment, seems to set off an exaggerated immune response in people with a genetic tendency, the National Heart, Lung, and Blood Institute (NHLBI) explains.
Many people have no symptoms; others have a dry cough, shortness of breath, deep fatigue, red bumps on the shins, red eyes or palpitations. Diagnosis combines a compatible picture, usually a biopsy showing granulomas, and ruling out tuberculosis, lymphoma and other causes. About two-thirds of people are free of the disease within two to three years, often without treatment, while others need medicines such as prednisolone or methotrexate to protect their organs.
Key takeaways
- Sarcoidosis is rare: the American Lung Association counts about 150,000 to 200,000 cases in the United States and roughly 27,000 new cases a year.
- Black women are three times more likely to be diagnosed than white women and tend to have more severe disease.
- No blood test proves sarcoidosis, but ACE, calcium, urine calcium, both forms of vitamin D, soluble IL-2 receptor, blood count and liver and kidney tests support it and detect complications.
- Sarcoidosis can raise blood and urine calcium: take vitamin D or calcium supplements only after both forms of vitamin D are checked.
- Treatment is needed when an important organ is threatened or symptoms are disabling; a 2025 trial showed methotrexate works as well as prednisolone as a first treatment for lung sarcoidosis.
What is sarcoidosis?
A granuloma is a cluster of white blood cells built to wall off something the immune system sees as harmful. In sarcoidosis, this process "goes off track", the NHLBI says, and granulomas form without a clear target. Persistent inflammation can turn into permanent scarring (fibrosis), especially in the lungs.
Sarcoidosis is not contagious and, according to Cleveland Clinic, is not classed as an autoimmune disease, even though the immune system drives it. It is also not cancer, although it can look like lymphoma on scans. A biopsy often tells them apart (see our guide to lymphoma symptoms and tests).
Who gets sarcoidosis?
Sarcoidosis can start at any age, but it often begins between 20 and 40, according to MedlinePlus, and the NHLBI notes that risk keeps rising with age, especially after 55. Other risk factors include:
- Sex: women are affected more often than men.
- Ancestry: risk is higher in people of African or Scandinavian descent. In the United States, Black patients tend to have more severe lung disease, more organs involved and higher rates of hospitalisation and death, a 2020 review in Frontiers in Immunology found.
- Family history: a person with a close blood relative who has sarcoidosis is nearly 5 times as likely to develop it (MedlinePlus).
- Environment and work: insecticides, mould and dust, in jobs such as health care, the automotive industry, farming and firefighting (NHLBI), or burn pits during military deployment (American Lung Association).
- Some medicines: certain HIV drugs and monoclonal antibodies used for cancer or immune diseases can trigger a sarcoidosis-like reaction.
Sarcoidosis symptoms
Symptoms depend on which organs are involved, and many people have none at all. General symptoms include extreme tiredness, fever, night sweats, unexplained weight loss, joint and muscle aches and swollen lymph nodes. The American Lung Association reports that severe fatigue can affect up to 70% of patients, even when inflammation is controlled.
Sarcoidosis of the lungs
The lungs and chest lymph nodes are the most common sites, and almost all people with sarcoidosis have some lung or chest symptoms, according to MedlinePlus: a dry cough, shortness of breath, wheezing and chest pain, often behind the breastbone. Lung sarcoidosis can also be silent.
Skin, eyes, heart and nervous system
- Skin: red, tender bumps on the shins (erythema nodosum), raised reddish-purple patches on the nose, cheeks and ears (lupus pernio, more frequent in African Americans), or bumps in old scars or tattoos.
- Eyes: red, painful or light-sensitive eyes, blurred vision, dry eyes. A 2025 review reports eye involvement in more than half of patients, sometimes silent. Our article on conjunctivitis vs uveitis explains which red-eye signs need urgent care.
- Heart: palpitations, an irregular heartbeat, fainting, swelling of the legs or shortness of breath from heart failure.
- Nervous system (neurosarcoidosis): headaches, weakness of one side of the face, seizures, numbness or tingling, vision problems, and intense thirst and urination (diabetes insipidus).
- Other organs: enlarged liver or spleen, swollen salivary glands, kidney stones.
Löfgren syndrome: the acute, gentle form
Löfgren syndrome is a sudden start with fever, arthritis in several joints, erythema nodosum and enlarged chest lymph nodes. It is most common in women aged 30 to 40 (NHLBI) and usually resolves within six months to two years (Cleveland Clinic). Because the picture is so typical, the American Thoracic Society (ATS) suggests skipping a lymph node biopsy, with close follow-up.
Sarcoidosis stages on the chest X-ray
Doctors describe lung sarcoidosis with the Scadding (or Siltzbach) stages, based on the chest X-ray. The stages describe where granulomas are, not severity, and you do not move through them in order (Cleveland Clinic).
- Stage 0: normal chest X-ray (sarcoidosis may be elsewhere in the body).
- Stage I: enlarged lymph nodes in the centre of the chest only. It often has no symptoms and frequently resolves on its own.
- Stage II: enlarged lymph nodes plus granulomas in the lung tissue.
- Stage III: granulomas in the lung tissue without enlarged nodes.
- Stage IV: pulmonary fibrosis, the only stage with permanent, irreversible scarring.
Lower stages resolve more often without treatment, but serious symptoms and other organs can be involved at any stage (American Lung Association).
How sarcoidosis is diagnosed
The 2020 ATS clinical practice guideline lists three criteria: a compatible clinical presentation, non-necrotizing granulomatous inflammation in one or more tissue samples, and the exclusion of other causes of granulomas. It warns that the diagnosis is "never fully secure", so follow-up matters.
Imaging
- Chest X-ray: the first test; it sets the stage.
- Chest CT: shows nodes, nodules and scarring in detail and guides biopsy.
- PET scan, heart or brain MRI: look for active inflammation.
- Lung function tests: measure breathing capacity and track treatment.
Biopsy, EBUS and ruling out mimics
The easiest tissue is sampled first, such as a skin lesion. For enlarged chest lymph nodes, the ATS suggests endobronchial ultrasound (EBUS), a needle biopsy done through a bronchoscope, rather than surgery (mediastinoscopy) as the first procedure. Infections that cause granulomas, especially tuberculosis and fungi, must be excluded; see our guide to tuberculosis tests.
Blood and urine tests for sarcoidosis
Blood tests support the diagnosis, look for hidden organ involvement and monitor treatment. The ATS guideline makes a strong recommendation for a baseline serum calcium test in every patient, and conditional recommendations for serum creatinine, alkaline phosphatase and a complete blood count, each repeated about once a year.
ACE level in sarcoidosis
Granulomas make angiotensin-converting enzyme (ACE). A 2022 meta-analysis of 35 studies (8,645 people) found that ACE has a sensitivity of only 60% but a specificity of 93%: a high ACE supports the diagnosis, a normal one does not exclude it. ACE also rises in other conditions (hyperthyroidism, diabetes, liver and some lung diseases) and falls with prednisolone and ACE-inhibitor pills such as lisinopril, MedlinePlus notes.
Calcium, urine calcium and vitamin D
Granulomas contain an enzyme, 1-alpha-hydroxylase, that turns stored vitamin D (25-OH) into its active form (1,25-dihydroxyvitamin D, or calcitriol). The typical pattern is a low or normal 25-OH vitamin D, a high 1,25-dihydroxyvitamin D and too much calcium in the blood or urine. The ATS guideline found high blood calcium in about 6% of patients on routine testing; high urine calcium can also cause kidney stones and kidney damage.
So a low 25-OH vitamin D blood test does not automatically call for supplements. The ATS recommends measuring both forms first, and a 2020 review advises supplementing only people with low 25-OH and a normal or low 1,25 level. The general rules on vitamin D deficiency need adapting in sarcoidosis. A high calcium with a low or normal parathyroid hormone (PTH) points to a cause outside the parathyroid glands, such as granulomas.
Soluble IL-2 receptor, lysozyme and other markers
- Soluble interleukin-2 receptor (sIL-2R): reflects T-cell activation; a 2025 review calls it a high-sensitivity marker, useful for involvement outside the lungs. In a 2026 French study of 103 patients, sIL-2R detected active disease more often than ACE (sensitivity 75% versus 54%), and combining it with 1,25-dihydroxyvitamin D raised specificity to 94.6%.
- Lysozyme: a high-specificity marker, according to the same review.
- Complete blood count: a low lymphocyte count (lymphopenia) supports the diagnosis; the complete blood count also screens for anaemia.
- Liver tests: a raised alkaline phosphatase (ALP) and GGT can signal granulomas in the liver; see our guide to liver function tests.
- Kidney tests: creatinine and eGFR detect kidney damage from calcium or, more rarely, from granulomas.
- Heart markers: when cardiac sarcoidosis is suspected, high-sensitivity troponin T above 14 ng/L has been linked to worse outcomes (2025 review); troponin is read with the ECG and heart MRI.
Reference values and what can point to sarcoidosis
Always compare with the range on your own report.
| Test | Usual adult range (SI unit / US unit) | What can suggest sarcoidosis or a complication |
|---|---|---|
| Serum ACE | 9-67 U/L / 0.15-1.14 µkat/L (MedlinePlus; other labs, e.g. 16-65 IU/L) | Raised in about 60% of patients; lowered by prednisolone and ACE inhibitors |
| Total calcium (blood) | 2.20-2.58 mmol/L / 8.8-10.3 mg/dL | Above the range: hypercalcemia (about 6% of patients) |
| 24-hour urine calcium | 2.50-6.30 mmol/24 h / 100-250 mg/day | Above 7.5 mmol/24 h (300 mg/day): hypercalciuria, kidney stone risk |
| 25-OH vitamin D | 75-200 nmol/L / 30-80 ng/mL (target many experts recommend) | Often low or normal; does not reflect active vitamin D in sarcoidosis |
| 1,25-dihydroxyvitamin D | about 43-187 pmol/L / 18-78 pg/mL | High or high-normal with high calcium: granuloma activity |
| Soluble IL-2 receptor | Lab-specific, in U/mL or pg/mL | Raised with active disease |
| Alkaline phosphatase (ALP) | 40-129 IU/L / 0.68-2.19 µkat/L | Raised with GGT: possible liver involvement |
| GGT | 5-40 U/L / 0.08-0.67 µkat/L | Raised with ALP: liver granulomas or bile flow problem |
| Creatinine | Men 62-115 µmol/L / 0.7-1.3 mg/dL; women 44-84 µmol/L / 0.5-0.95 mg/dL | Raised: kidney damage from calcium or granulomas |
Ranges: MedlinePlus and Michigan Medicine Laboratories (1,25-dihydroxyvitamin D, converted to SI with the factor 2.4).
How to read your results
- High ACE alone, without symptoms or imaging findings, does not mean sarcoidosis: several other conditions raise it.
- High calcium plus high 1,25-dihydroxyvitamin D plus a low PTH is the classic sarcoidosis calcium pattern. A high calcium with a high PTH points instead to the parathyroid glands. If albumin is low, ask about a corrected calcium.
- On treatment, a falling ACE or sIL-2R can reflect response, but steroids lower ACE directly, so trends are read with symptoms and imaging.
Sarcoidosis treatment
The goal of treatment is remission and organ protection, not normal blood tests. Symptoms often improve without treatment, especially with small lung abnormalities (MedlinePlus). The 2021 European Respiratory Society (ERS) guidelines explain that the main reasons to treat are to lower the risk of serious organ damage or death, or to improve quality of life, depending on the organ involved.
First-line: corticosteroids, or methotrexate
Prednisolone remains the usual first choice (ERS), but long-term use causes weight gain, high blood sugar and blood pressure, mood changes, cataracts, glaucoma and osteoporosis. MedlinePlus notes that treatment may last 1 to 2 years. In the 2025 PREDMETH trial (New England Journal of Medicine), in 138 untreated patients with lung sarcoidosis, methotrexate improved lung function (forced vital capacity) as much as prednisone after 24 weeks (6.11 versus 6.75 percentage points). Prednisone more often caused weight gain, insomnia and increased appetite; methotrexate more often caused nausea, fatigue and abnormal liver tests.
Second- and third-line treatments
- Steroid-sparing drugs: methotrexate, azathioprine, leflunomide, mycophenolate, and antimalarials such as hydroxychloroquine, which may help skin or joint sarcoidosis (American Lung Association).
- Anti-TNF biologics: infliximab, or adalimumab, for severe or refractory disease. A 2025 Thorax meta-analysis found that anti-TNF drugs improved forced vital capacity by about 5.7 percentage points.
- Organ-specific care: eye drops for anterior uveitis, antibiotics of the tetracycline family for some skin forms, oxygen and pulmonary rehabilitation for lung scarring, an implantable defibrillator for dangerous heart rhythms, and rarely a transplant (NHLBI).
Cardiac sarcoidosis
Granulomas in the heart muscle can cause complete heart block, ventricular tachycardia, heart failure and sudden cardiac death, a 2024 European Society of Cardiology consensus reminds. The ATS therefore suggests a baseline ECG even without heart symptoms. Suspected cases get heart MRI or cardiac PET, with BNP and troponin. Treatment combines immunosuppression with heart failure medicines and, when needed, an implantable cardioverter-defibrillator.
Remission and outlook
Remission is the most common outcome: Cleveland Clinic reports that about two-thirds of people are disease-free within two to three years; MedlinePlus says up to half get better within three years without treatment. Disease still active after three years is likely to be chronic, yet only 10 to 20% of chronic cases cause permanent organ damage. Most people have a normal life expectancy; 1 to 5% of cases are fatal (Cleveland Clinic).
Flares are most frequent within six months of stopping treatment, and the risk falls the longer you stay well (NHLBI).
Fatigue, anxiety and living well with sarcoidosis
A 2025 systematic review of 43 studies found fatigue in 54% of patients, excessive daytime sleepiness in 51%, anxiety in 29% and depression in 25%. The NHLBI recommends counselling, especially cognitive therapy, support groups and, if needed, antidepressants; our guide to anxiety helps you know when to ask for help. Regular physical activity improves energy and breathlessness (NHLBI).
Diet and sarcoidosis
No diet cures sarcoidosis, but a few rules help:
- Favor an anti-inflammatory, mostly plant-based diet: fruits, vegetables, legumes and whole grains, less red meat, cheese and added sugar. Some research suggests it may help (Cleveland Clinic).
- Do not take vitamin D or calcium supplements on your own. If your calcium or urine calcium is high, the NHLBI advises drinking plenty of fluids, eating fewer calcium-rich foods and avoiding too much sun exposure.
- On steroids, limit salt and sugar, and check your blood calcium before any bone treatment with calcium or vitamin D.
- Avoid smoking, dust and secondhand smoke.
Pregnancy and children
Most women with sarcoidosis have healthy babies, the NHLBI says, though preterm birth, preeclampsia, bleeding and blood clots are more frequent; some medicines, such as methotrexate, are unsafe in pregnancy, so plan ahead. Sarcoidosis is rare in young children (MedlinePlus).
When to see a doctor
See your doctor promptly for a cough or breathlessness lasting weeks, red shin bumps with joint pain and fever, a red or painful eye, or fatigue with weight loss. If you have sarcoidosis, report palpitations, strong thirst or kidney stone pain.
Call 999 or go to the A&E if you have:
- sudden or severe shortness of breath, or chest pain;
- fainting, a very slow or very fast heartbeat;
- sudden vision loss, a severe headache, a seizure, weakness of the face, arm or leg;
- confusion, vomiting and extreme thirst, which can signal very high calcium;
- coughing up a significant amount of blood.
Latest scientific advances in sarcoidosis
Methotrexate as a first-line alternative to prednisone
The Dutch PREDMETH trial (NCT04314193), published in 2025, is the first randomised trial to compare first-line methotrexate and prednisone. Methotrexate was non-inferior for lung function at 24 weeks, with a different but not lighter side-effect profile. For you: the first treatment can now be chosen according to your priorities.
Efzofitimod: a negative phase 3 trial, but a lesson on steroids
Efzofitimod is an infused fusion protein that targets neuropilin-2 on immune cells. The phase 3 EFZO-FIT trial (NCT05415137), published in The Lancet Respiratory Medicine in October 2026, treated 268 patients in nine countries for 48 weeks. It did not reduce steroid doses more than placebo. Yet in all groups, the average prednisone dose fell from 10.7 to 2.9 mg a day during the planned taper. For you: ask whether your steroid dose can be lowered safely.
JAK inhibitors and other targeted drugs
JAK inhibitors, mainly tofacitinib, block signals that granulomas depend on. A 2025 review in Current Opinion in Pulmonary Medicine describes encouraging results in case series and two prospective open-label trials in skin and lung sarcoidosis. The 2025 Thorax meta-analysis calls the evidence in skin disease "limited but promising". Larger trials are under way: brepocitinib in cutaneous sarcoidosis (phase 2/3, 168 adults, NCT06978725) and baricitinib in cardiac sarcoidosis (phase 2a, NCT06868381). None is approved for sarcoidosis yet.
Better biopsies with EBUS cryobiopsy
Cryobiopsy freezes and removes a larger piece of lymph node. In a 2026 randomised trial in China, EBUS cryobiopsy found sarcoidosis in 98.0% of cases, versus 82.7% with the standard needle. A 2026 meta-analysis of 24 studies (2,182 patients) confirmed a higher diagnostic yield (90.8% versus 74.5%), with no procedure-related deaths. The DETECTION-SAR-II trial (NCT07246876, 410 patients) is testing whether it can replace multiple biopsy techniques.
Which tests can help?
If sarcoidosis is suspected or confirmed, ask your doctor whether these tests are right for you:
- serum calcium yearly and, with stones or borderline calcium, a 24-hour urine calcium;
- 25-OH and 1,25-dihydroxy vitamin D before any vitamin D supplement, plus PTH if calcium is high;
- ACE, soluble IL-2 receptor and a complete blood count;
- liver and kidney panels;
- an ECG, and troponin, BNP and heart MRI if heart involvement is suspected;
- an eye exam, chest imaging and lung function tests;
- regular blood count and liver tests on methotrexate.
Glossary
- Granuloma: a small cluster of immune cells that forms in response to inflammation.
- Scadding stages: a 0 to IV classification of lung sarcoidosis based on the chest X-ray.
- Löfgren syndrome: an acute form with a good outcome.
- Lupus pernio: a chronic reddish-purple skin form on the nose, cheeks and ears; unrelated to lupus.
- EBUS: endobronchial ultrasound-guided biopsy of chest lymph nodes.
- ACE: angiotensin-converting enzyme, an enzyme produced by granulomas and measured in the blood.
- Calcitriol: 1,25-dihydroxyvitamin D, the active form of vitamin D; granulomas can make too much of it.
Frequently asked questions
What is sarcoidosis in simple terms?
The immune system forms tiny inflamed lumps (granulomas) in organs such as the lungs, skin or eyes. It is not contagious or cancer, and often goes away on its own.
What are the different stages of sarcoidosis?
Five X-ray stages: 0 normal, I chest lymph nodes, II nodes plus lungs, III lungs only, IV permanent scarring. Only stage IV is irreversible.
Can sarcoid go into remission?
Yes. About two-thirds of people are disease-free within two to three years, often without treatment. Flares are most common in the six months after stopping treatment.
Does sarcoidosis cause anxiety?
It often does: a 2025 review found anxiety in about 29% of patients and depression in about 25%, with fatigue in more than half. Counseling and support groups help; tell your doctor.
What is a good diet plan for someone with sarcoidosis?
A mostly plant-based diet with plenty of fluids, little sugar and salt, and no vitamin D or calcium supplements without testing.
What ACE level indicates sarcoidosis?
There is no single cut-off. A level above your lab's upper limit (often around 65 to 67 U/L) supports the diagnosis, but ACE is normal in about 4 in 10 people with sarcoidosis and can be high in other diseases. It is always interpreted with imaging and a biopsy.
Sources
- Crouser ED et al. — Diagnosis and Detection of Sarcoidosis (ATS guideline) — Am J Respir Crit Care Med, 2020 — doi.org
- Baughman RP et al. — ERS clinical practice guidelines on treatment of sarcoidosis — Eur Respir J, 2021 — doi.org
- Kahlmann V et al. — First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate — N Engl J Med, 2025 — doi.org
- Culver DA et al. — Efzofitimod versus placebo in pulmonary sarcoidosis (EFZO-FIT) — Lancet Respir Med, 2026 — doi.org
- Bechman K et al. — Biologic and targeted synthetic therapies in sarcoidosis: meta-analysis — Thorax, 2025 — doi.org
- Nunes H, Hindré R, Jeny F — New therapeutic options in sarcoidosis — Curr Opin Pulm Med, 2025 — doi.org
- Zapata-Huizi JJ et al. — Advances in Sarcoidosis — Arch Bronconeumol, 2026 — doi.org
- Sharma R et al. — Management of cardiac sarcoidosis — Eur Heart J, 2024 — doi.org
- Hu X et al. — Serum ACE in diagnosing sarcoidosis: a meta-analysis — Biomolecules, 2022 — doi.org
- Pascual MB et al. — Biomarkers in Sarcoidosis — Semin Respir Crit Care Med, 2025 — doi.org
- Pagis V et al. — Soluble IL-2 receptor and sarcoidosis activity — Rev Med Interne, 2026 — doi.org
- Zhou Y, Lower EE — Calcium metabolism and bone health in sarcoidosis — Semin Respir Crit Care Med, 2020 — doi.org
- Sandu CA et al. — Ocular Sarcoidosis — Rom J Ophthalmol, 2025 — doi.org
- Frans A et al. — Psychiatric symptoms in sarcoidosis: meta-analysis — Front Med, 2025 — doi.org
- Hena KM — Sarcoidosis Epidemiology: Race Matters — Front Immunol, 2020 — doi.org
- Deng M et al. — EBUS mediastinal cryobiopsy: a randomized trial — Med, 2026 — doi.org
- Gupta N et al. — EBUS cryobiopsy versus EBUS-TBNA: meta-analysis — Respir Investig, 2026 — doi.org
- ClinicalTrials.gov — Brepocitinib in adults with cutaneous sarcoidosis, NCT06978725 — clinicaltrials.gov
- ClinicalTrials.gov — Baricitinib in patients with cardiac sarcoidosis, NCT06868381 — clinicaltrials.gov
- ClinicalTrials.gov — DETECTION-SAR-II, NCT07246876 — clinicaltrials.gov
- NHLBI — Sarcoidosis health topic — National Institutes of Health, 2022 — nhlbi.nih.gov
- MedlinePlus — Sarcoidosis — National Library of Medicine, 2025 — medlineplus.gov
- MedlinePlus — ACE blood test — National Library of Medicine, 2025 — medlineplus.gov
- MedlinePlus — Calcium - urine and related tests — National Library of Medicine — medlineplus.gov
- Michigan Medicine Laboratories — Vitamin D, 1,25 Dihydroxy — mlabs.umich.edu
- American Lung Association — Learn About Sarcoidosis, 2026 — lung.org
- Cleveland Clinic — Sarcoidosis — my.clevelandclinic.org
- NHS — Sarcoidosis — nhs.uk, page last reviewed 6 October 2022 — https://www.nhs.uk/conditions/sarcoidosis/
Further reading
- Calcium blood test and the bone and mineral panel
- GGT test: liver enzyme results explained
- High globulin level: causes and next steps
- CRP blood test: read your inflammation results
- Blood tests for fatigue: what new CDC data show
- Heart failure: symptoms, causes and treatment
- Depression: symptoms, causes and diagnosis
Understand your lab results with AI DiagMe
Sarcoidosis leaves traces in many blood and urine tests: calcium, urine calcium, both forms of vitamin D, ACE, lymphocytes, liver enzymes and creatinine. AI DiagMe reads your lab report in minutes, explains each value in plain language, points out patterns such as high calcium with low PTH, and suggests questions to ask your doctor. Upload your lab results to AI DiagMe for a clear, personal report.



